SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-24-013460
Filing Date
2024-10-22
Accepted
2024-10-22 17:11:23
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20241021xs3.htm S-3 308539
2 EX-5.1 tmb-20241021xex5d1.htm EX-5.1 13139
3 EX-23.1 tmb-20241021xex23d1.htm EX-23.1 4427
4 EX-FILING FEES tmb-20241021xexfees.htm EX-FILING FEES 50153
5 GRAPHIC tmb-20241021xex5d1002.jpg GRAPHIC 4308
6 GRAPHIC tmb-20241021xs3001.jpg GRAPHIC 11611
  Complete submission text file 0001558370-24-013460.txt   399741
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282777 | Film No.: 241387026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)